U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock of late, which are much lower than the gains experienced till mid-February. The San Francisco, ...

President Donald Trump’s promise to impose tariffs on pharmaceutical imports is raising red flags among generic drugmakers and industry experts, who warn that such a move could lead to increased drug ...

University of California, Davis, researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that ...

In his first major action on health care costs this term, President Donald Trump issued a multi-part executive order on Tuesday aimed at lowering drug prices and reducing costs for Medicare. The move ...

Shares of Mural Oncology plc (NASDAQ: MURA) are soaring Monday following the company's announcement that it will discontinue clinical development of its lead drug candidate Nemvaleukin and begin ...

Johnson & Johnson’s Q1 2025 earnings reveal growth in sales and EPS, boosted by MedTech and Pharma. Click for my updated look at JNJ and its most recent news.

While 2025 began on a positive note for the pharmaceutical industry, things have taken a sharp turn amid escalating fears of ...

The third unstoppable stock to purchase with $300 right now, despite the Nasdaq being mired in a bear market, is rapidly ...

The president is expected to impose tariffs on pharmaceuticals, though full details of the plan have not yet been announced.

Trump recently proposed tariffs on pharmaceutical products. Experts say this could lead to added costs, drug shortages and ...

A Cyclothon 2.0 will be organised from April 5 to April 27 as part of Haryana’s drug de-addiction campaign, aimed at raising public awareness about the ill- effects of substance abuse.